Chinese COVID-19 Vaccine Could Be Ready by December

By Tom Glover, August 21, 2020

0 0

A Chinese pharmaceutical company recently developed a potential COVID-19 vaccine that could be ready to hit the market by the end of December, priced at under RMB1,000 (USD144) for two doses.

Announcing this promising news in the long, attritional battle against the pandemic, Liu Jingzhen, chairman of the China National Pharmaceutical Group (Sinopharm), said that the marketing review procedure will start after overseas phase III clinical trials are completed. 

The vaccine has begun late-stage testing on humans in the United Arab Emirates in order to get proof of efficacy for regulatory approval, Guangming Daily reported on Tuesday.

Liu goes on to state that “It will not be priced very high. It is expected to cost a few hundred yuan for a shot, and for two shots it should be less than RMB1,000.”

He also suggested that not all of China’s 1.4 billion citizens will need to be vaccinated, saying that students and city workers are a priority, while those living in smaller, rural areas may not need to be vaccinated at all.

Meanwhile, another Chinese vaccine candidate has received a patent. It has been co-developed by the Academy of Military Sciences and CanSino Biologics Inc., a high-tech biopharmaceutical company, according to a report by People’s Daily.

While the National Intellectual Property Administration approved the patent on August 16, some Chinese netizens mistook the news for meaning that the vaccine had already come to market. 

With more than 200 vaccine candidates in development around the world, among them 20 currently undergoing human clinical trials, there is a lot of pressure on governments and vaccine makers to deliver a successful candidate.

However, public health experts are still cautioning the public that vaccines need to be put through the appropriate clinical trials before approval. “Having a vaccine... and proving that a vaccine is safe and effective are two different things,” said US National Institute for Allergy and Infectious Diseases Director Dr. Anthony Fauci in a recent interview on ABC News.

Fauci expressed his doubts over the world’s first COVID-19 vaccine claimed by Russia earlier this month. The country’s Ministry of Health issued a registration certificate for the vaccine candidate after only testing 76 people, Science reported.

[Cover image via Pixabay]

more news

China's Yuan Appreciates to Two-Year High Against the US Dollar

It's been quite a rollercoaster for the yuan this year, which was 7.17 against the US dollar on May 27.

Journey to Cretaceous China in New Episode of China Untold Podcast

For this episode of China Untold, host Matt Bossons introduces you to Qianzhousaurus and the people studying it.

This Week in History: The Birth of Sun Yat-sen, Father of Modern China

To this day, more than 150 years after his birth, Sun is one of the most revered political figures among Chinese people.

New COVID-19 Cases Reported Across Chinese Mainland

In recent days, cases have been reported in Shanghai, Tianjin, Anhui and Yunnan.

UPDATE: New Local COVID-19 Case Confirmed in Shanghai

A baggage handler at Shanghai Pudong International Airport has tested positive for COVID-19.

China Reports Over 100 New Daily COVID-19 Cases

The Chinese mainland reported 101 new COVID-19 cases, including 98 domestically transmitted and three imported.

China Confirms 68 COVID-19 Cases in One Day, Highest Since April

Chinese health authorities reported 68 confirmed cases of COVID-19 yesterday, the highest single day spike on the mainland since April.

Rising COVID-19 Cases in China Lead to Extensive Testing

With daily COVID-19 cases on the rise, health authorities are conducting comprehensive nucleic acid testing.

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at thatsonline for events, guides, giveaways and much more!

7 Days in China With

Weekly updates to your email inbox every Wednesday


Download previous issues

Never miss an issue of That's Magazines!

Visit the archives